Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
10/12/2018 | 14:31 | GlobeNewswire Inc. | Edison issues initiation on ADL Bionatur Solutions (BNT) | AMEX:ADL | Amdl, |
10/12/2018 | 14:30 | GlobeNewswire Inc. | Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand | AMEX:ADL | Amdl, |
18/09/2009 | 20:32 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ADL | Amdl, |
18/09/2009 | 15:30 | PR Newswire (US) | AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US | AMEX:ADL | |
20/08/2009 | 15:49 | PR Newswire (US) | AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc. | AMEX:ADL | |
19/08/2009 | 23:30 | PR Newswire (US) | AMDL Inc. Announces Second Quarter 2009 Financial Results | AMEX:ADL | |
19/08/2009 | 23:23 | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ADL | Amdl, |
14/08/2009 | 22:10 | Edgar (US Regulatory) | Notification that Quarterly Report will be submitted late (NT 10-Q) | AMEX:ADL | Amdl, |
14/08/2009 | 22:00 | PR Newswire (US) | AMDL Inc. Files Notification of Late Filing for Form 10-Q | AMEX:ADL | |
22/07/2009 | 15:30 | PR Newswire (US) | AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009 | AMEX:ADL | |
08/07/2009 | 16:00 | PR Newswire (US) | AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test | AMEX:ADL | |
06/07/2009 | 12:04 | Edgar (US Regulatory) | Revised Proxy Soliciting Materials (definitive) (DEFR14A) | AMEX:ADL | Amdl, |
06/07/2009 | 12:04 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | AMEX:ADL | Amdl, |
25/06/2009 | 23:30 | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (PRER14A) | AMEX:ADL | Amdl, |
23/06/2009 | 18:08 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(4) (424B4) | AMEX:ADL | Amdl, |
17/06/2009 | 15:30 | PR Newswire (US) | AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 | AMEX:ADL | |
15/06/2009 | 23:33 | PR Newswire (US) | AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes | AMEX:ADL | |
11/06/2009 | 20:39 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | AMEX:ADL | Amdl, |
16/05/2009 | 00:10 | PR Newswire (US) | AMDL, Inc. Announces First Quarter 2009 Financial Results | AMEX:ADL | |
15/05/2009 | 22:59 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3) | AMEX:ADL | Amdl, |
14/05/2009 | 00:00 | PR Newswire (US) | AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer | AMEX:ADL | |
08/05/2009 | 15:30 | PR Newswire (US) | AMDL Inc.'s JJB Plant Receives Production Approval From Chinese State Food and Drug Administration (SFDA) | AMEX:ADL | |
07/05/2009 | 18:30 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (D) | AMEX:ADL | Amdl, |
06/05/2009 | 21:51 | PR Newswire (US) | AMDL Inc. Announces First Closing of Private Placement of 12% Series Two Senior Notes | AMEX:ADL | |
30/04/2009 | 15:30 | PR Newswire (US) | AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer Test | AMEX:ADL | |
29/04/2009 | 15:30 | PR Newswire (US) | Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets | AMEX:ADL | |
15/04/2009 | 23:58 | PR Newswire (US) | AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets | AMEX:ADL | |
15/04/2009 | 22:47 | Edgar (US Regulatory) | Annual Report (10-K) | AMEX:ADL | Amdl, |
03/04/2009 | 22:02 | Edgar (US Regulatory) | Amended Notification that Annual Report will be submitted late (NT 10-K/A) | AMEX:ADL | Amdl, |
31/03/2009 | 12:01 | Edgar (US Regulatory) | Notification that Annual Report will be submitted late (NT 10-K) | AMEX:ADL | Amdl, |